Prototype of a rapid assay for cellular mechanotransduction

William Craelius

Research output: Contribution to journalConference articlepeer-review


Many key cellular interactions involve mechanotransduction (MT), whereby forces applied by other cells or by the matrix lead to biochemical and morphological sequellae. Since MT may be a useful target of molecular therapies, I have developed a rapid assay for it: the flow cytomechanical assay (FCMA). The assay exposes suspended cells to graded hydrostatic challenges prior to their entry into a standard flow cytometer. Preliminary results on 7 cell types have shown that FCMA can measure key aspects of MT at a rate of 10,000 cells per minute. FCMA could be a useful screening tool for agents and materials that involve MT.

Original languageEnglish (US)
Pages (from-to)324-326
Number of pages3
JournalAnnual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings
StatePublished - 2002
EventProceedings of the 2002 IEEE Engineering in Medicine and Biology 24th Annual Conference and the 2002 Fall Meeting of the Biomedical Engineering Society (BMES / EMBS) - Houston, TX, United States
Duration: Oct 23 2002Oct 26 2002

All Science Journal Classification (ASJC) codes

  • Signal Processing
  • Biomedical Engineering
  • Computer Vision and Pattern Recognition
  • Health Informatics


  • Cell volume regulation
  • Flow cytometry
  • Mechanotransduction
  • Tamoxifen


Dive into the research topics of 'Prototype of a rapid assay for cellular mechanotransduction'. Together they form a unique fingerprint.

Cite this